Physician profile

Eric L Mansfield

Otolaryngology · Fayetteville, NC

NPI 1679544829

$8,605.09

in general payments reported to CMS, 2019-2025

38 companies · $1,284 in 2025

The $1,284 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,823.81
Education$183.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,421.99 2019-2025 Nucala, Trelegy Ellipta, Shingrix
Regeneron Healthcare Solutions, INC. $1,379.17 2019-2025 Dupixent
Astrazeneca Pharmaceuticals LP $1,027.41 2020-2025 Fasenra, Airsupra, Breztri
Genzyme Corporation $889.75 2019-2025
Medtronic, INC. $725.28 2021-2023 Propel, Nuvent
Stryker Corporation $392.82 2019-2024 Clarifix Cryotherapy Device
Optinose US, INC. $356.73 2019-2024
Hologic Sales and Service, LLC $198.17 2024-2025 Coolseal Generator
Acclarent, INC $195.68 2019-2023 Trudi Nav Cable
Novartis Pharmaceuticals Corporation $157.67 2019-2025
Intersect Ent, INC. $139.78 2019-2022
Genentech USA, INC. $133.75 2019-2024 Xolair
Hikma Pharmaceuticals USA $129.36 2022-2024 Ryaltris
Amgen INC. $128.35 2022-2025 Tezspire
Smith+Nephew, INC. $118.46 2021-2025 Stravix
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Alk-Abello, INC $109.59 2020-2023 Odactra, Ragwitek, Grastek
Ars Pharmaceuticals Operations, INC. $107.52 2025 Neffy
Sanofi-Aventis U.S. LLC $89.00 2025
Integra Lifesciences Corporation $83.29 2025 Relieva Spinplus Nav, Trudi Probe, Inspira Air
Aerin Medical INC. $81.90 2019-2025
Phadia US INC. $77.90 2019-2022
Abbvie INC. $73.48 2021-2023
Acelrx Pharmaceuticals, INC. $73.38 2020-2021
Biohaven Pharmaceutical Holding Company LTD. $71.37 2022
Grifols USA, LLC $66.26 2025 Prolastin-C Liquid
Aytu Biopharma, INC. $60.92 2020-2022
Pfizer INC. $47.21 2023
Merck Sharp & Dohme LLC $44.64 2023-2025 Keytruda
Biohaven Pharmaceuticals, INC. $38.45 2021
Shire North American Group INC $37.26 2019
Forte Bio-Pharma LLC $35.15 2021
Teva Pharmaceuticals USA, INC. $26.23 2022
Organon LLC $21.77 2025 Nexplanon
Inspire Medical Systems, INC. $17.88 2025 Inspire
Boehringer Ingelheim Pharmaceuticals, INC. $15.58 2022
Arbor Pharmaceuticals, INC. $12.71 2019
Medtronic USA, INC. $12.29 2019
Phathom Pharmaceuticals, INC. $6.94 2025 Voquezna

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric L Mansfield

$8,605.09

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $1,284 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).

https://glasscript.com/doctor/348622/eric-l-mansfield

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.